Twist Bioscience Corporation

NasdaqGS TWST

Twist Bioscience Corporation Net Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD -208.73 M

Twist Bioscience Corporation Net Income is USD -208.73 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -2.01% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Twist Bioscience Corporation Net Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -204.62 M, a 6.08% change year over year.
  • Twist Bioscience Corporation Net Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -217.86 M, a -43.24% change year over year.
  • Twist Bioscience Corporation Net Income for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -152.10 M, a -8.69% change year over year.
  • Twist Bioscience Corporation Net Income for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -139.93 M, a -29.96% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
NasdaqGS: TWST

Twist Bioscience Corporation

CEO Dr. Emily Marine Leproust Ph.D.
IPO Date Oct. 31, 2018
Location United States
Headquarters 681 Gateway Boulevard
Employees 919
Sector Health Care
Industries
Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Similar companies

NTRA

Natera, Inc.

USD 165.76

-2.09%

CDNA

CareDx, Inc

USD 22.05

-12.05%

ICLR

ICON Public Limited Company

USD 200.24

-8.14%

PSNL

Personalis, Inc.

USD 5.13

-4.11%

EXAS

Exact Sciences Corporation

USD 54.20

-7.37%

ILMN

Illumina, Inc.

USD 136.48

-5.37%

IQV

IQVIA Holdings Inc.

USD 197.96

-3.26%

CSTL

Castle Biosciences, Inc.

USD 25.46

-2.64%

GH

Guardant Health, Inc.

USD 37.46

-1.68%

A

Agilent Technologies, Inc.

USD 143.43

1.04%

WAT

Waters Corporation

USD 404.93

1.26%

TMO

Thermo Fisher Scientific Inc.

USD 556.99

0.27%

DHR

Danaher Corporation

USD 237.62

-0.94%

MTD

Mettler-Toledo International Inc.

USD 1.27 K

0.33%

StockViz Staff

January 15, 2025

Any question? Send us an email